- Condition: Diabetic Neuropathic Pain
Interventions: Drug: ABT-652 6 mg; Drug: ABT-652 12 mg; Drug: ABT-652 12 mg - 18 mg; Drug: Placebo comparator; Drug: Duloxetine
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004; Drug: Duloxetine; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Drug: duloxetine; Drug: sugar pill
Sponsors: Northwestern University; Northwestern University; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Pelvis Pain Chronic
Intervention: Drug: Duloxetine
Sponsors: University of Maryland; University of Maryland; Eli Lilly and Company
Recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Chronic Pain
Intervention: Drug: duloxetine, diclofenac
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Research Resources (NCRR); Merck; Nuvo Research Inc.
Recruiting - verified March 2012 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Escitalopram; Drug: BMS-820836 Placebo; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified August 2011 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Placebo matching with BMS-820836; Drug: BMS-820836; Drug: Duloxetine; Drug: Placebo matching with Duloxetine
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Systemic Lupus Erythematosus
Intervention: Drug: Cymbalta
Sponsors: Brain Resource Center; Brain Resource Center
Recruiting - verified December 2010 - Condition: Fibromyalgia
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Anxiety Neuroses; Anxiety States, Neurotic; Neuroses, Anxiety
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Fibromyalgia
Interventions: Drug: Duloxetine; Procedure: Skin biopsy
Sponsors: Albany Medical College; Albany Medical College
Recruiting - verified December 2010 - Condition: Generalized Anxiety Disorder
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Pregnancy
Intervention: Drug: duloxetine
Sponsors: Eli Lilly and Company; Eli Lilly and Company; INC Research, LLC
Recruiting - verified February 2012 - Condition: Alcohol Dependence
Interventions: Drug: Pregabalin; Drug: Duloxetine; Behavioral: Standardized behavioral therapy; Behavioral: Standardized behavioral therapy; Drug: Placebo; Behavioral: Standardized behavioral therapy
Sponsors: The Scripps Research Institute; The Scripps Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified June 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressants through Texas Medication Algorithm (TMA); Behavioral: Brief Interpersonal Psychotherapy (IPT-B)
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Diabetic Neuropathic Pain; Chronic Low Back Pain
Interventions: Drug: donepezil; Drug: duloxetine; Drug: donepezil 2.5 mg and duloxetine 30mg; Drug: placebo; Drug: gabapentin
Sponsors: Wake Forest University; Wake Forest University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Conditions: Postpartum Depression; Major Depressive Disorder
Intervention: Drug: duloxetine
Sponsors: Yale University; Yale University
Recruiting - verified June 2011 - Condition: Depression
Interventions: Drug: Standard antidepressant therapy (SADT); Behavioral: Motivational antidepressant therapy (MADT)
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Obsessive Compulsive Disorder
Intervention: Drug: Duloxetine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eli Lilly and Company
Recruiting - verified July 2011 - Condition: Multiple Sclerosis
Intervention: Drug: Duloxetine
Sponsors: Brown, Theodore R., M.D., MPH; Brown, Theodore R., M.D., MPH; Eli Lilly and Company
Recruiting - verified October 2011 - Condition: Depression
Interventions: Drug: Escitalopram; Drug: Duloxetine; Behavioral: Cognitive behavioral therapy (CBT)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Emory University
Recruiting - verified December 2011
 |
Cymbalta Clinical Trials |
